Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > RDHL Redhill Biopharma > Detailed Quotes

RDHL Redhill Biopharma

0.517
-0.003-0.58%
Trading Session 09/28 12:45 ET
High
0.532
Open
0.530
Turnover
326.25K
Low
0.501
Pre Close
0.520
Volume
634.34K
Market Cap
32.98M
P/E(TTM)
Loss
52wk High
6.500
Shares
63.82M
P/E(Static)
Loss
52wk Low
0.473
Float Cap
26.41M
Bid/Ask %
45.46%
Historical High
22.220
Shs Float
51.11M
Volume Ratio
0.30
Historical Low
0.473
Dividend TTM
--
Div Yield TTM
--
P/B
-6.30
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.24%
Amplitude
5.98%
Avg Price
0.514
Lot Size
1
Float Cap
26.41M
Bid/Ask %
45.46%
Historical High
22.220
Shs Float
51.11M
Volume Ratio
0.30
Historical Low
0.473
Dividend TTM
--
P/B
-6.30
Dividend LFY
--
Turnover Ratio
1.24%
Amplitude
5.98%
Avg Price
0.514
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
RedHill Biopharma Ltd. develops medicines for gastrointestinal and infectious diseases. It operates through Commercial Operations, and the Research and Development segments. The Commercial Operations segment covers all areas relating to the commercial sales and is being performed by the subsidiary in the U.S. The Research and Development segment includes the study and licensing of therapeutic candidates. Its products include Talicia, Movantik, and Aemcolo. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.
CEO: Mr. Dror Ben-Asher
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...